Skip to main content
Clinical Trials/ISRCTN19517317
ISRCTN19517317
Completed
未知

A randomised controlled feasibility Trial of Intraoperative Cell salvage vs donor blood Transfusion in Ovarian Cancer surgery (TICTOC)

Royal Cornwall Hospitals NHS Trust0 sites57 target enrollmentNovember 11, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Specialty: Cancer, Primary sub-specialty: Gynae
Sponsor
Royal Cornwall Hospitals NHS Trust
Enrollment
57
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30389760 protocol (added 01/11/2019)

Registry
who.int
Start Date
November 11, 2016
End Date
June 30, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. 18 years old or over
  • 2\. Suspected or confirmed ovarian cancer (newly diagnosed) requiring cytoreductive surgery, whether primary or interval (following chemotherapy)
  • 3\. CT scan evidence (with or without clinical evidence) compatible with FIGO stage III/IV ovarian cancer/ primary peritoneal cancer at presentation\*
  • 4\. ECOG Performance Status 0\-1
  • 5\. Willing to participate and able to give written informed consent
  • \*CT features of pelvic mass (or features suggestive of primary peritoneal cancer) and extrapelvic involvement including ascites, omental disease, peritoneal thickening, bowel surface and/or mesentery involvement, enlarged pelvic and para\-aortic lymph nodes, evidence of disease on diaphragm

Exclusion Criteria

  • 1\. Diagnosis of concurrent malignancy
  • 2\. Pregnant
  • 3\. Donor transfusion during the week prior to surgery
  • 4\. Haemoglobinopathies (e.g. sickle cell, thalassaemia)
  • 5\. Unwilling to accept donor blood (e.g. on religious grounds)

Outcomes

Primary Outcomes

Not specified

Similar Trials